Danatlas Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $20.7M

  • Investors
  • 9

Danatlas General Information

Description

Manufacturer of pharmaceutical products designed to advance the discovery and development of innovative therapies for complex diseases. The company offers proprietary drug discovery platforms, translational research capabilities, and small-molecule oncology drug development programs, enabling biotechnology companies, healthcare organizations, and patients to access novel targeted treatment options and improved therapeutic outcomes.

Contact Information

Website
danatlas.com
Formerly Known As
Beijing Danqing Pharmaceutical Technology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 101, 2nd Floor, Building 4, Zone 2
  • Number 7, Liangshuihe First Street, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Room 101, 2nd Floor, Building 4, Zone 2
  • Number 7, Liangshuihe First Street, Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010

Danatlas Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Danatlas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 03-Mar-2025 $20.7M Completed Generating Revenue
4. Early Stage VC 11-Jan-2024 Completed Generating Revenue
3. Early Stage VC 23-Feb-2023 Completed Generating Revenue
2. Secondary Transaction - Private 29-Jun-2022 Completed Generating Revenue
1. Early Stage VC 25-Mar-2022 Completed Generating Revenue
To view Danatlas’s complete valuation and funding history, request access »

Danatlas Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayland Capital Corporate Venture Capital Minority
Panlin Capital Venture Capital Minority
Shanghai Guofang Private Equity Fund Management Growth/Expansion Minority
Wuxi AstraZeneca CICC Venture Capital Partnership Venture Capital Minority
Yizhuang Guotou Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Danatlas FAQs

  • When was Danatlas founded?

    Danatlas was founded in 2021.

  • Where is Danatlas headquartered?

    Danatlas is headquartered in Beijing, China.

  • What industry is Danatlas in?

    Danatlas’s primary industry is Drug Discovery.

  • Is Danatlas a private or public company?

    Danatlas is a Private company.

  • What is Danatlas’s current revenue?

    The current revenue for Danatlas is .

  • How much funding has Danatlas raised over time?

    Danatlas has raised $20.7M.

  • Who are Danatlas’s investors?

    Bayland Capital, Panlin Capital, Shanghai Guofang Private Equity Fund Management, Wuxi AstraZeneca CICC Venture Capital Partnership, and Yizhuang Guotou are 5 of 9 investors who have invested in Danatlas.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process